title: Clinical Practice Guideline for Management of Primary Aldosteronism: What is New in the 2016 Update?
abstract: Primary Aldosteronism is the single most common cause of secondary hypertension and is associated with increased target organ injury. The Endocrine Society has recently released the updated Clinical Practice Guideline for Primary Aldosteronism entitled "The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline". We review the updated Clinical Practice Guideline, highlighting the new recommendations and the implications that they may have in clinical practice. The recognition by the Endocrine Society's Task Force that Primary Aldosteronism is a public health issue and that the population at risk for screening should be significantly expanded will surely have an impact in the clinical practice which hopefully will translate in better detection, diagnosis and treatment of patients with Primary Aldosteronism.
authors.affiliation: Department of Biochemistry, University of Mississippi Medical Center Jackson, USA; Women's Health Research Center, University of Mississippi Medical Center and Jackson, USA; Cardio-Renal Research Center, University of Mississippi Medical Center Jackson, USA.
authors.forename: Damian G
authors.initials: DG
authors.lastname: Romero
authors.affiliation: Women's Health Research Center, University of Mississippi Medical Center and Jackson, USA; Cardio-Renal Research Center, University of Mississippi Medical Center Jackson, USA; Department of Physiology and Biophysics, University of Mississippi Medical Center Jackson, USA; Department of Medicine, University of Mississippi Medical Center Jackson, USA.
authors.forename: Licy L
authors.initials: LL
authors.lastname: Yanes Cardozo
keywords: Adrenocorticotrophic hormone; Aldosterone-producing adenoma; Primary Aldosteronism